1 line
No EOL
11 KiB
Text
1 line
No EOL
11 KiB
Text
<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0"><channel><title>NIDDK Small Business Funding Opportunities</title><link>https://www.niddk.nih.gov/research-funding/current-opportunities?ac=sb</link><description>All small business funding opportunities currently available from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</description><language>en</language><item><guid isPermaLink="false">{7ECF9706-0BE3-4339-94F6-2A41CB85F144}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-247</link><title>PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)</title><description>This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) invites eligible United States small businesses to submit Small Business Technology Transfer (STTR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH awarding components identified in this NOFO are encouraged to submit STTR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).<br/>This Parent Funding Opportunity Announcement does not accept clinical trials.</description><pubDate>Wed, 03 Jul 2024 11:07:04 -0400</pubDate></item><item><guid isPermaLink="false">{5D744286-03DF-47B0-8584-3B17B9D84E1E}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-246</link><title>PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)</title><description>This Notice of Funding Opportunity Announcement (NOFO), issued by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH and CDC awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).<br/>This Parent Funding Opportunity Announcement requires that at least 1 clinical trial be proposed. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions.</description><pubDate>Wed, 03 Jul 2024 11:06:41 -0400</pubDate></item><item><guid isPermaLink="false">{ADEEC7DA-3549-41A1-B1F6-00047A7D4ACD}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/pa-24-245</link><title>PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)</title><description>This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).<br/>This Parent Funding Opportunity Announcement does not accept clinical trials.</description><pubDate>Wed, 03 Jul 2024 11:05:32 -0400</pubDate></item><item><guid isPermaLink="false">{5624AB74-7FFB-4ADA-A0CC-481D46A2BF61}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-24-131</link><title>Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)</title><description>Through this Notice of Funding Opportunity (NOFO), the National Institutes of Health (NIH) aims to facilitate the career development and transition of investigators new to entrepreneurship with an interest in small business by simultaneously supporting their entrepreneurial development and the conduct of research and development under their direction.<br/>This NOFO supports small business concerns (SBCs) in employing and developing researchers as entrepreneurial Program Directors/Principal Investigators (PDs/PIs). In addition to augmenting scientific research staff and supporting research and development efforts at SBCs, a major component of this NOFO is entrepreneurial training, mentoring, and career development of the PD/PI. Optimal PDs/PIs for this award are scientists and professionals with strong research, technology development, and/or healthcare delivery skills and experience, but limited entrepreneurial and independent research project leadership experience. PDs/PIs are expected to grow their entrepreneurial skillset while working in a small business to develop promising technologies and products that align with NIH's mission to improve health and save lives.</description><pubDate>Thu, 25 Apr 2024 13:26:12 -0400</pubDate></item><item><guid isPermaLink="false">{9E1A507C-E42E-437D-A323-18989BC108FE}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-od-24-079</link><title>Notice of Special Interest: Womens Health Research</title><description>In alignment with the White House Initiative on Women’s Health Research, the National Institutes of Health (NIH) is issuing this Notice of Special Interest to highlight interest in receiving research applications focused on diseases and health conditions that predominantly affect women (e.g., autoimmune diseases; depressive disorders, Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD), gender-based-violence), present and progress differently in women (e.g., cardiovascular disease; HIV; reproductive aging and its implications), or are female-specific (e.g., uterine fibroids; endometriosis; menopause).<br/><br/>For consideration under this NOSI, applications must have a central focus on the health of women, as demonstrated through specific aims that EITHER explicitly address a particular condition in women OR focus on one of the high priority topics below. In either approach, intersectional and/or multidimensional approaches that consider the health of women in context (e.g., projects accounting for social and structural variables—including race, ethnicity, socioeconomic status , and State and Federal policies— that affect women’s health) are strongly encouraged. For consideration under this NOSI, projects are not required to exclusively focus on women. However, studies that include more than one sex or gender should be designed and powered to make generalizable conclusions about women and enable sex or gender difference comparison.</description><pubDate>Tue, 26 Mar 2024 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{5DBEB765-7FAF-451F-A55E-32715FF89D37}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/rfa-md-24-006</link><title>Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)</title><description>This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to develop a product, process or service for commercialization with the aim of improving minority health and/or reducing and ultimately eliminating health disparities in one or more populations that experience health disparities. Appropriate technologies should be effective, affordable, and culturally acceptable.</description><pubDate>Fri, 08 Mar 2024 15:00:09 -0500</pubDate></item><item><guid isPermaLink="false">{B0AC02DA-79A5-483F-92EB-3A22E1F581CC}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-24-007</link><title>Notice of Special Interest (NOSI): Addressing Health Disparities and Advancing Health Equity in NIDDK Diseases</title><description>This NOSI invites applications for research to understand and mitigate health disparities in the prevention, development, diagnosis, treatment and progression of diseases and conditions of high priority to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It is recognized that health disparities are driven by factors operating at multiple levels (i.e., individual, interpersonal, community, societal) and domains (e.g., biological, behavioral, sociocultural, physical/built environment, etc.) and interacting in complex ways. (Refer to the NIMHD Minority Health and Health Disparities Research Framework.)</description><pubDate>Wed, 20 Dec 2023 00:00:00 -0500</pubDate></item><item><guid isPermaLink="false">{C241B69D-87AE-45AD-82BD-52AED7C7A975}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/not-dk-23-015</link><title>Notice of Special Interest (NOSI): Next-Generation Approaches to Renal Replacement Therapy Including Vascular Access</title><description>This NOSI aims to support the development of innovative approaches to renal replacement therapy and address critical accompanying challenges such as vascular access and fluid management during dialysis. </description><pubDate>Mon, 14 Aug 2023 00:00:00 -0400</pubDate></item><item><guid isPermaLink="false">{B31BC606-0B65-4E70-A7E8-D82A6D1D6216}</guid><link>https://www.niddk.nih.gov/research-funding/current-opportunities/par-23-219</link><title>SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)</title><description>The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications from small business concerns (SBCs) to the newly re-authorized Commercialization Readiness Pilot (CRP) program. The NOFO aims to facilitate the transition of previously or currently funded SBIR and STTR Phase II and Phase IIB projects to the commercialization stage by providing additional support for technical assistance and later stage research and development (R and D) not typically supported through Phase II or Phase IIB grants or contracts. This may include independent replication of key studies, Investigational New Drug (IND)-enabling studies, clinical studies, manufacturing costs, regulatory assistance, or a combination of services. Although a significant amount of the work in a CRP award may be subcontracted to other institutions, the Small Business Concern (SBC) is expected to maintain oversight and management of the R and D throughout the award.<br/>Clinical Trials are not accepted under this NOFO.</description><pubDate>Wed, 12 Jul 2023 14:28:32 -0400</pubDate></item></channel></rss> |